AYTU BIOPHARMA, INC Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $0.00.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for the quarter ending 2020-12-31 was $1.06M.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $92.88K.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for the quarter ending 2016-06-30 was $1.09M.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.06M, a 58.97% decline from fiscal 2020.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for fiscal 2020 was $2.58M, a 44.75% decline from fiscal 2019.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for fiscal 2019 was $4.67M.
- AYTU BIOPHARMA, INC stock issued during period, value, conversion of convertible securities for fiscal 2016 was $10.09M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $1.06M 10-K · filed 2022-09-27 |
| 2020-12-31 | $1.06M 10-Q · filed 2021-05-17 | |
| 2020-06-30 | $2.58M 10-K · filed 2020-10-06 | |
| 2020-03-31 | $92.88K 10-Q · filed 2021-05-17 | |
| 2019-06-30 | $4.67M 10-K · filed 2020-10-06 | |
| 2016-06-30 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $10.09M 10-K · filed 2017-08-31 |
| 2014-08-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2015-04-15 | $90.00K 10-Q · filed 2015-04-15 |
| 2011-08-31 | $49.06K 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |